MGMT and breast cancer: MGMT methylation was detected in 61 (or 10%) of the 611 controls and in 17.4% (122 out of 700) of the BC patients; the mean age of these participants was 56 ± 12.46 (95% CI 53.89–58.36) years (Table 1B).